Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1064238rdf:typepubmed:Citationlld:pubmed
pubmed-article:1064238lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:1064238lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:1064238lifeskim:mentionsumls-concept:C0681867lld:lifeskim
pubmed-article:1064238lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:1064238lifeskim:mentionsumls-concept:C0011884lld:lifeskim
pubmed-article:1064238lifeskim:mentionsumls-concept:C0023694lld:lifeskim
pubmed-article:1064238lifeskim:mentionsumls-concept:C0206012lld:lifeskim
pubmed-article:1064238lifeskim:mentionsumls-concept:C2827738lld:lifeskim
pubmed-article:1064238pubmed:issue2lld:pubmed
pubmed-article:1064238pubmed:dateCreated1976-8-2lld:pubmed
pubmed-article:1064238pubmed:abstractTextAn interim analysis of the cases in the British Multicentre Photocoagulation Trial shows that treated eyes with maculopathy retain better visual acuity than untreated eyes. The difference of the change in the mean visual acuities of the treated and untreated eyes is small but statistically significant. In those with new vessels as the predominant feature, there is a trend for treated eyes to have better visual acuity than untreated eyes, but the difference in the mean visual acuity of the two groups is not statistically significant.lld:pubmed
pubmed-article:1064238pubmed:languageenglld:pubmed
pubmed-article:1064238pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1064238pubmed:citationSubsetIMlld:pubmed
pubmed-article:1064238pubmed:statusMEDLINElld:pubmed
pubmed-article:1064238pubmed:monthJullld:pubmed
pubmed-article:1064238pubmed:issn0078-5334lld:pubmed
pubmed-article:1064238pubmed:authorpubmed-author:ChengHHlld:pubmed
pubmed-article:1064238pubmed:issnTypePrintlld:pubmed
pubmed-article:1064238pubmed:volume95lld:pubmed
pubmed-article:1064238pubmed:ownerNLMlld:pubmed
pubmed-article:1064238pubmed:authorsCompleteYlld:pubmed
pubmed-article:1064238pubmed:pagination351-7lld:pubmed
pubmed-article:1064238pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1064238pubmed:meshHeadingpubmed-meshheading:1064238-...lld:pubmed
pubmed-article:1064238pubmed:meshHeadingpubmed-meshheading:1064238-...lld:pubmed
pubmed-article:1064238pubmed:meshHeadingpubmed-meshheading:1064238-...lld:pubmed
pubmed-article:1064238pubmed:meshHeadingpubmed-meshheading:1064238-...lld:pubmed
pubmed-article:1064238pubmed:meshHeadingpubmed-meshheading:1064238-...lld:pubmed
pubmed-article:1064238pubmed:meshHeadingpubmed-meshheading:1064238-...lld:pubmed
pubmed-article:1064238pubmed:meshHeadingpubmed-meshheading:1064238-...lld:pubmed
pubmed-article:1064238pubmed:meshHeadingpubmed-meshheading:1064238-...lld:pubmed
pubmed-article:1064238pubmed:year1975lld:pubmed
pubmed-article:1064238pubmed:articleTitleMulticentre trial of xenon-arc photocoagulation in the treatment of diabetic retinopathy. A Randomized controlled study. Interim report.lld:pubmed
pubmed-article:1064238pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1064238pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1064238pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1064238lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1064238lld:pubmed